A revised international prognostic score system for WM
Kastritis E, et al.
Leukemia · 2019
Key Findings
- ●Revised IPSSWM with age, B2M >=4, albumin <3.5, LDH >=250
- ●Five prognostic groups with 10-year survival: 84% to 9%
- ●Improved risk stratification over original IPSSWM
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: pmid-31118465DOI: 10.1038/s41375-019-0431-yPMID: 31118465